These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 5850868)

  • 1. [Iatrogenic jaundice. Observation of a case following administration of the ethyl ester of 4-4'-dioxycoumarinyl acetic acid (Tromexan)].
    Miracco A; Orlando V
    Riforma Med; 1965 Aug; 79(32):878-9. PubMed ID: 5850868
    [No Abstract]   [Full Text] [Related]  

  • 2. [A new synthetic anticoagulant, the ethyl ester of dioxycoumarinyl-acetic acid or tromexan].
    BICKEL G; DELLA SANTA R
    Rev Med Suisse Romande; 1949 Sep; 69(9):545-58. PubMed ID: 18140885
    [No Abstract]   [Full Text] [Related]  

  • 3. [A case of ingestion of ethyl ester of bis-4-oxycoumarinyl acetic acid (tromexan) in suicide attempt].
    CATALANO V; NAVAZIO F
    Prog Med (Napoli); 1956 May; 12(9):274-5. PubMed ID: 13336168
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapeutic value of a new anticoagulant: the ethyl ester of di-3,3'-(4-oxycoumarinyl) acetic acid].
    LIAN C; SIGUIER F; WELTI JJ; COBLENTZ B; NEDEY ; BREYNAERT
    Sem Hop; 1951 May; 27(35):1511-22. PubMed ID: 14866256
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pharmacological properties and physiological effects of a new anticoagulant: the ethyl ester of di-3,3'-(4-oxycoumarinyl) acetic acid].
    LIAN C; SIGUIER F; WELTI JJ; PIETTE M; POULLAIN P; PHILIPPON J
    Sem Hop; 1951 May; 27(35):1505-11. PubMed ID: 14866255
    [No Abstract]   [Full Text] [Related]  

  • 6. Control of ethyl biscoumacetate (tromexan) therapy by standardized clotting time of whole blood.
    MAYER GA; CONNELL WF
    Can Med Assoc J; 1957 Nov; 77(10):930-8. PubMed ID: 13479846
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of anticoagulants in dermatology; use of tromexan (ethyl ester of di-4-hydroxy-coumarinyl acetic acid) in ulcus cruris in dystrophy with thrombophlebitis and in related conditions].
    PANCONESI E
    Rass Dermatol Sifilogr; 1951; 4(2):74-105. PubMed ID: 14892261
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinically significant interaction between the new diuretic--tienienilic acid and the antithrombotic drugs, derivatives of coumarin].
    Prandota J; Panków-Prandota L
    Przegl Lek; 1982; 39(5):385-8. PubMed ID: 7122922
    [No Abstract]   [Full Text] [Related]  

  • 9. [A case of bilateral adrenal hematoma occuring during antiocoagulant treatment].
    Labram C; Aime D; Rousselot R
    Sem Hop; 1966 Feb; 42(7):437-9. PubMed ID: 4286212
    [No Abstract]   [Full Text] [Related]  

  • 10. [A recent case of fatal abdominal complications due to abusive usage of anticoagulants].
    Francillon J; Vignal J; Lesbros F
    Lyon Chir; 1968; 64(4):703-5. PubMed ID: 5309659
    [No Abstract]   [Full Text] [Related]  

  • 11. [Laryngeal asphyxia during pelentan therapy].
    Pihrt
    Cesk Otolaryngol; 1966 Mar; 15(2):112-5. PubMed ID: 5931611
    [No Abstract]   [Full Text] [Related]  

  • 12. [Extensive necrosis of the thigh as a complication following treatment with coumarin and phenylindandion derivatives].
    Mieszczerski J
    Przegl Lek; 1965; 21(7):515-7. PubMed ID: 5848477
    [No Abstract]   [Full Text] [Related]  

  • 13. [Currural paralysis and anticoagulant treatment].
    Vigouroux RA; Roger J; Giraud M; Gosset A; Hassoun J; Duport P
    Rev Neurol (Paris); 1968 Feb; 118(2):144-9. PubMed ID: 5699633
    [No Abstract]   [Full Text] [Related]  

  • 14. [Occlusive complications of prolonged anti-coagulant treatments].
    Roseau E
    J Chir (Paris); 1965; 90(1):75-86. PubMed ID: 5840298
    [No Abstract]   [Full Text] [Related]  

  • 15. [Spontaneous subdural hematoma during anticoagulant treatment].
    Tournoux P; Bouchard C; Comoy ; Chevet
    Bull Mens Soc Med Mil Fr; 1965 May; 59(5):275-80. PubMed ID: 5897408
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacokinetics of ethyl biscoumacetate and its metabolite 7-hydroxy ethyl biscoumacetate in healthy volunteers.
    Perlík F; Patzelová V
    Int J Clin Pharmacol Ther; 1994 Nov; 32(11):622-4. PubMed ID: 7874379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharyngeal hematomas complicating an anticoagulant treatment].
    Ray J; Coudert P; Coudert M
    Presse Med (1893); 1969 Dec; 77(54):2054. PubMed ID: 5378464
    [No Abstract]   [Full Text] [Related]  

  • 18. [Blood coagulation tests following prolonged pelentan treatment of patients recovering from myocardial infarction].
    Rysavý F
    Vnitr Lek; 1965 Nov; 11(11):1065-75. PubMed ID: 5849390
    [No Abstract]   [Full Text] [Related]  

  • 19. [Apropos of abdominal complications of anticoagulant treatment].
    Peycelon R; Delore X; Porta JP; Dalle-Vacche G
    Lyon Chir; 1966 May; 62(3):388-91. PubMed ID: 5945427
    [No Abstract]   [Full Text] [Related]  

  • 20. Tromexan-3,3'-carboxymethylenebis (4-hydroxycoumarin) ethyl ester; experimental and clinical properties.
    BURKE GE; WRIGHT IS
    Circulation; 1951 Feb; 3(2):164-70. PubMed ID: 14812644
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.